Olaris, Inc., a leader in metabolomics and precision medicine, today announced a strategic investment from Bruker Corporation , a global leader in scientific instrumentation and diagnostics solutions.

Scientists learned about a decade ago that when children were given peanuts in the first few months of life, their chances of developing a peanut allergy... | Cell And Molecular Biology ...

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

The innate immune system is the first on the scene when a pathogen enters the body. Different cells of this response include eosinophils, basophils, neutrophils, natural killer cells, macrophages, ...

“These pro-allergic T cells are more inflammatory than anything previously described in this context,” said Järvinen-Seppo, chief of Pediatric Allergy and Immunology at UR Medicine Golisano Children’s ...

As the field of engineered ex vivo cell therapies continues to progress, significant advancements are occurring in both the complexity and diversity of these therapies. T cells are distinguished by ...

Thetis cells, a class of immune cells first described in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.